Literature DB >> 7789055

Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause.

F P Cantatore1, G Loverro, A M Ingrosso, R Lacanna, E Sassanelli, L Selvaggi, M Carrozzo.   

Abstract

The effect of oestrogen replacement on bone metabolism and serum cytokine levels (IL1,IL6) was investigated in surgical menopause. The study included 40 female subjects; 10 healthy premenopausal women underwent total hysterectomy without oophorectomy. Thirty healthy premenopausal women underwent total hysterectomy with bilateral oophorectomy. They were randomly divided into 3 groups of 10 subjects. The first group received natural estradiol (0.05 mg/day) for 6 months; the second group received natural estradiol (0.05 mg/day) and medroxyprogesteron acetate (10 mg/day) for 6 months, the third group received no therapy. Calcium-phosphorus metabolism, inflammatory indices, serum IL1 and IL6 levels were tested before and 6 months after surgery in all patients. A significant increase in serum alkaline phosphatase, urinary cross-links, serum PTH and IL1-IL6 was observed in the untreated women with total hysterectomy and oophorectomy. No significant variation in any of the parameters considered was observed in patients treated with oestrogen, in those treated with oestrogens and medroxyprogesteron nor in patients without oophorectomy. These results in human "in vivo" confirm that ovarian steroids play an important role in regulating the production of IL1 and IL6 which could regulate bone resorption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789055     DOI: 10.1007/bf02214935

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype.

Authors:  N Kurihara; C Civin; G D Roodman
Journal:  J Bone Miner Res       Date:  1991-03       Impact factor: 6.741

2.  Interleukin-6: an osteotropic factor?

Authors:  G D Roodman
Journal:  J Bone Miner Res       Date:  1992-05       Impact factor: 6.741

3.  Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol.

Authors:  L R Chaudhary; T C Spelsberg; B L Riggs
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

4.  Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

Authors:  G D Roodman; N Kurihara; Y Ohsaki; A Kukita; D Hosking; A Demulder; J F Smith; F R Singer
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

5.  Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.

Authors:  R Pacifici; C Brown; E Puscheck; E Friedrich; E Slatopolsky; D Maggio; R McCracken; L V Avioli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  Evidence of estrogen receptors in normal human osteoblast-like cells.

Authors:  E F Eriksen; D S Colvard; N J Berg; M L Graham; K G Mann; T C Spelsberg; B L Riggs
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

7.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Avian osteoclasts as estrogen target cells.

Authors:  M J Oursler; P Osdoby; J Pyfferoen; B L Riggs; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Thyroid function and bone turnover.

Authors:  J W Bijlsma; S A Duursma; J M Roelofs; P J der Kinderen
Journal:  Acta Endocrinol (Copenh)       Date:  1983-09

10.  The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones.

Authors:  T J Chambers; P M McSheehy; B M Thomson; K Fuller
Journal:  Endocrinology       Date:  1985-01       Impact factor: 4.736

View more
  8 in total

Review 1.  The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Authors:  Anna M Barron; Giuseppe Verdile; Ralph N Martins
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 2.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.

Authors:  Marek Bolanowski; Jacek Daroszewski; Marek Medraś; Beata Zadrozna-Sliwka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 4.  Osteocyte: the unrecognized side of bone tissue.

Authors:  G Y Rochefort; S Pallu; C L Benhamou
Journal:  Osteoporos Int       Date:  2010-03-04       Impact factor: 4.507

5.  Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis.

Authors:  N Ishimaru; K Saegusa; K Yanagi; N Haneji; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

6.  Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction.

Authors:  R J O'Keefe; R N Rosier; L A Teot; J M Stewart; D G Hicks
Journal:  Iowa Orthop J       Date:  1998

7.  Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6.

Authors:  Kate M Edwards; Paul J Mills
Journal:  Maturitas       Date:  2008-11-17       Impact factor: 4.342

8.  Olive oil and vitamin D synergistically prevent bone loss in mice.

Authors:  Camille Tagliaferri; Marie-Jeanne Davicco; Patrice Lebecque; Stéphane Georgé; Marie-Jo Amiot; Sylvie Mercier; Amélie Dhaussy; Alain Huertas; Stéphane Walrand; Yohann Wittrant; Véronique Coxam
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.